Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MNC Kapital Indonesia Tbk (BCAP) vs Ikapharmindo Putramas Tbk. (IKPM) Price & Performance

MNC Kapital Indonesia TbkTrade
Ikapharmindo Putramas Tbk.Trade

Price performance (Past 24H)

Key statistics

MNC Kapital Indonesia Tbk vs Ikapharmindo Putramas Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 424K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp196 (market cap 333.56B, 96.7K 24h volume). The key difference: MNC Kapital Indonesia Tbk is far larger — about 6.4× Ikapharmindo Putramas Tbk.'s market cap, and MNC Kapital Indonesia Tbk is more actively traded (424K versus 96.7K). Which is the better fit depends on your goals.

BCAPIKPM
Market Cap
2.13T333.56B
Volume
424K96.7K
Lot
4.24K967
Turnover
21.2M19.03M
Average Price
50196.81
Value
21.2M19.03M
Indicative Equilibrium Price
50
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCAP
View details
IKPM
View details

About MNC Kapital Indonesia Tbk

PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.

Read more on BCAP

About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.

Read more on IKPM